New Frontiers and Treatments Advances for Metastatic Enteropancreatic Neuroendocrine Tumors: What Do We Know? What Do We Still Need to Know? Michael A. Morse, MD - Program Chair

New Frontiers and Treatments Advances for Metastatic Enteropancreatic Neuroendocrine Tumors: What Do We Know? What Do We Still Need to Know? Michael A. Morse, MD - Program Chair


Published

May 31, 2015

Created by

CMEducation Resources symposium